Indian Markets Eye Recovery on US Tariff Relief Hopes and India-EU Trade Deal Progress
Indian markets are positioned for potential recovery despite technical weakness, supported by US tariff relief hopes, India-EU trade deal progress, and RBI's ₹2 lakh crore liquidity injection. Key beneficiaries include pharmaceutical and chemical stocks, while technical indicators suggest continued caution with Nifty 50 support at 24,850.

*this image is generated using AI for illustrative purposes only.
Indian stock market benchmark indices Sensex and Nifty 50 are expected to stage a rebound in the holiday-shortened week, supported by hopes of relief from US tariff measures and expectations around progress on the India-European Union trade agreement. Markets remained closed on January 26, 2026, for Republic Day, with trading resuming Tuesday on BSE and NSE.
Both indices witnessed sharp sell-offs on Friday, weighed down by persistent foreign institutional investor outflows, heightened geopolitical uncertainties, caution ahead of Union Budget 2026, and mixed corporate earnings for the December quarter. However, several key weekend developments may improve market sentiment.
US Tariff Relief Provides Hope
The Indian equity market could find support after US Treasury Secretary Scott Bessent signaled the possibility of rolling back additional 25% tariffs on India. Bessent indicated "there could be a path" to removing the levies, noting that India's purchases of Russian oil have declined sharply following tariff measures imposed by the Donald Trump administration.
India-EU Trade Deal Expectations Build
European leaders have arrived in India for the 16th India-EU Summit, where discussions will center on advancing a Free Trade Agreement aimed at strengthening bilateral trade ties. Progress on the India-EU trade deal could provide a counter-cyclical buffer for the Indian economy by enhancing export participation in global value chains, expanding market access, and supporting supply-chain diversification.
| Trade Parameter: | Current Status | Projection |
|---|---|---|
| EU Share of India's Exports: | 17.30% | - |
| EU Share of India's Imports: | 8.40% | - |
| Potential Export Increase: | - | $50 billion by 2031 |
Madhavi Arora, Lead Economist at Emkay Global Financial Services Ltd, estimates that bilateral alignment could lift India's exports to the EU by $50 billion by 2031, led by medium-tech manufacturing. "Improved import efficiency and higher FDIs would further support productivity gains and tech transfers, while greater regulatory certainty could aid IT services exports, where the EU already accounts for approximately one-third of demand," Arora said.
Key beneficiary stocks from the likely India-EU trade deal include:
Pharmaceutical Sector:
- Dr Reddy's Laboratories
- Lupin
- Sun Pharmaceutical Industries
Chemicals Sector:
- SRF
- Navin Fluorine
- Gujarat Fluorochemicals
- Aarti Industries
RBI Announces Major Liquidity Injection
The Reserve Bank of India announced on Friday it will inject over ₹2 lakh crore of liquidity into the system through multiple measures:
| Liquidity Measure: | Amount | Timeline |
|---|---|---|
| Variable Rate Repo Operation: | ₹25,000 crore | January 30, 2026 |
| USD/INR Buy-Sell Swap: | $10 billion (₹91,000 crore) | February 4, 2026 |
| Government Bond Purchases: | ₹1 lakh crore total | February 5 & 12, 2026 |
The central bank will undertake government bond purchases under open market operations, including ₹50,000 crore each on February 5 and February 12.
Technical Outlook Remains Challenging
Nifty 50 plunged 2.51% last week amid heavy selling pressure across all sectors, weakening the overall market structure. The benchmark index decisively slipped below its key 200-day EMA, signaling a negative trend. The 21-day EMA crossing below the 55-day EMA confirms bearish momentum.
| Technical Level: | Value | Significance |
|---|---|---|
| Immediate Support: | 24,850 | Key downside level |
| Secondary Support: | 24,600 | Break below target |
| Resistance Level: | 25,250 | Recovery threshold |
| Secondary Resistance: | 25,500 | Sustained strength target |
Dr. Ravi Singh, Chief Research Officer from Master Capital Services Ltd, noted that immediate support for Nifty 50 is placed near 24,850, with a break below potentially dragging the index toward 24,600. On the upside, resistance stands at 25,250, while sustained strength above this could lead to recovery toward 25,500.

































